Cytogenetic analysis of 355 cases of fetal loss in different trimesters

Prenatal Diagnosis

Volumn 31, Issue 2, 2011, Pages 152-158

  Zhang, Lin ^a   Zhang, Xiao hong ^a   Wang, Jian liu ^a   Ren, Mei hong ^a   Pei, Qiu yan ^a   Wei, Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Amniocentesis; Chorionic villus; Chromosome; Karyotype; Placenta; Skin biopsy

Indexed keywords

AGE DISTRIBUTION; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FETUS; FETUS DEATH; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LABOR INDUCTION; MAJOR CLINICAL STUDY; PLACENTA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SKIN BIOPSY; THIRD TRIMESTER PREGNANCY; TISSUE CULTURE; UMBILICAL CORD;

ADULT; CYTOGENETIC ANALYSIS; FEMALE; FETAL DEATH; GENETIC COUNSELING; HUMANS; PREGNANCY; PREGNANCY TRIMESTERS; YOUNG ADULT;

EID: 79251505297     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2665     Document Type: Article

References (31)

1. Alessandri LM, Stanley FJ, Newnham J, Walters BN. 1992. The epidemiological characteristics of unexplained antepartum stillbirths. Early Hum Dev 30: 147-161.
2. Brady K, Duff P, Harlass FE, Reid S. 1991. Role of amniotic fluid cytogenetic analysis in the evaluation of recent fetal death. Am J Perinatol 8: 68-70.
3. Buitendijk S, Zeitlin J, Cuttini M, Langhoff-Roos J, Bottu J. 2003. Indicators of fetal and infant health outcomes. Eur J Obstet Gynecol Reprod Biol 111: S66-S77.
4. Faye-Petersen OM, Guinn DA, Wenstrom KD. 1999. Value of perinatal autopsy. Obstet Gynecol 94: 915-920.
5. Fretts RC. 2005. Etiology and prevention of stillbirth. Am J Obstet Gynecol 193: 1923-1935.
6. Frias AE Jr, Luikenaar RA, Sullivan AE, et al. 2004. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 104(3): 521-526.
7. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. 2005. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 331: 1113-1117.
8. Goldenberg RL, Kirby R, Culhane JF. 2004. Stillbirth: a review. J Matern Fetal Neonatal Med 16: 79-94.
9. Incerpi MH, Miller DA, Samadi R, Settlage RH, Goodwin TM. 1998. Stillbirth evaluation: What tests are needed? Am J Obstet Gynecol 178: 1121-1125.
10. Katiyar R, Kriplani A, Agarwal N, Bhatla N, Kabra M. 2007. Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and risk in maternal serum alpha feto protein. Prenat Diagn 24: 139-142.
11. Khare M, Howarth E, Sadler J, Healey K, Konje JC. 2005. A comparison of prenatal versus postnatal karyotyping for the investigation of intrauterine fetal death after the first trimester of pregnancy. Prenat Diagn 25: 1192-1195.
12. Kline J, Stein Z. 1987. Epidemiology of chromosomal abnormalities in spontaneous abortion: prevalence, manifestation and determinants. In Spontaneous and Recurrent Abortion, Bennett MJ, Edmonds DK (eds). Blackwell Scientific Publications: Oxford (United Kingdom); 29-50.
13. Korteweg FJ, Bouman K, Erwich JJHM, et al. 2008. Cytogenetic analysis after evaluation of 750 fetal deaths. Obstet Gynecol 111(4): 865-874.
14. Kramer MS, Liu S, Luo Z, et al. 2002. Analysis of perinatal mortality and its components: time for a change? Am J Epidemiol 156: 493-497.
15. Michalski ST, Porter J, Pauli RM. 2002. Costs and consequences of comprehensive stillbirth assessment. Am J Obstet Gynecol 186: 1027-1034.
16. Neiger R, Croom CS. 1990. Cytogenetic study of amniotic fluid in the evaluation of fetal death. J Perinatol 10: 32-34.
17. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. 1996. Antiphospholipid antibodies and fetal death. Obstet Gynecol 87: 489-493.
18. Pauli RM, Reiser CA. 1994. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1, 000 referrals. Am J Med Genet 50: 135-153.
19. Petersson K, Bremme K, Bottinga R, et al. 2002. Diagnostic evaluation of intrauterine fetal deaths in Stockholm 1998-99 [published erratum appears in Acta Obstet Gynecol Scand 2003;82:102]. Acta Obstet Gynecol Scand 81: 284-292.
20. Rey E, Kahn SR, David M, Shrier I. 2003. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361: 901-908.
21. Robinson WP, McFadden DE, Barrett IJ, et al. 2002. Origin of amnion and implications for evaluation of the fetal genotype in cases of mosaicism. Prenat Diagn 22: 1078-1087.
22. Rodgers CS, Creasy MR, Fitchett M, Maliszewska CT, Pratt NR, Waters JJ. 1996. Solid tissue culture for cytogenetic analysis: a collaborative survey for the Association of Clinical Cytogeneticists. J Clin Pathol 49: 638-641.
23. Sharma PP, Salihu HM, Oyelese Y, Ananth CV, Kirby RS. 2006. Is race a determinant of stillbirth recurrence? Obstet Gynecol 107: 391-397.
24. Simoni G, Fraccaro M. 1992. Does confined placental mosaicism affect the fetus? Hum Reprod 7: 139-140.
25. Silver RM. 2007a. Fetal death. Obstet Gynecol 109(1): 153-167.
26. Silver RM. 2007b. Fetal death [published erratum appears in Obstet Gynecol 2007;110:191]. Obstet Gynecol 109: 153-167.
27. Stetten G, Escallon CS, South ST, McMichael JL, Saul DO, Blakemore KJ. 2004. Reevaluating confined placental mosaicism. Am J Med Genet 131: 232-239.
28. Vogel Motulsky F (Luo huiyuan interpretation). 2002. Human Genetics Springer: The Separate Principle and the Choice of Prenatal Diagnosis (1st edn). Renmin Medicinal Publication: Beijing (China); 64-67.
29. Wapner RJ, Lewis D. 2002. Genetics and metabolic causes of stillbirth. Semin Perinatol 26: 70-74.
30. Weeks JW, Asrat T, Morgan MA, Nageotte M, Thomas SJ, Freeman RK. 1995. Antepartum surveillance for a history of stillbirth: when to begin? Am J Obstet Gynecol 172: 486-492.
31. Wolstenholme J, Rooney DE, Davison EV. 1994. Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective UK collaborative survey. Prenat Diagn 14: 345-361.